Evidence map›Paper›PMID 36751394›Full record

ArticleCentral-European journal of immunology2022

Generation of high cross-presentation ability human dendritic cells by combination of interleukin 4, interferon β and GM-CSF.

Yihua Pi, Yifang Li, Rongyi Liang, Jian Xiao, Jing Leng, Lifeng Zhang

Open access · goldAbstract read
In one paragraph

Article in Central-European journal of immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yihua Pi *Guangxi University of Chinese Medicine, China.
Yifang Li *The Second People's Hospital of Hunan Province, China.
Rongyi Liang *Guangxi University of Chinese Medicine, China.
Jian XiaoGuangxi University of Chinese Medicine, China.
Jing LengGuangxi University of Chinese Medicine, China.
Lifeng ZhangGuangxi University of Chinese Medicine, China.
Guangxi University of Chinese Medicine · CNXian Yang Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dendritic cell (DC)-based immunotherapies have been utilized for the treatment of numerous diseases. However, the conventional generation strategies of DCs in vitro require 7 days and these DCs showed an unsatisfactory function, which prompted us to explore new approaches. We found that in vitro culture of human CD14

Indexed as

cDC1cross-presentationdendritic cellIFN-βIL-4

Identifiers

PMID36751394
PMCPMC9894086
OpenAlexW4285506767

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.